SIC
GILD icon

Salem Investment Counselors’s Gilead Sciences GILD Stock Holding History

Salem Investment Counselors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$175K Buy
1,389
+120
+9% +$15.8K ﹤0.01% 420
2026
Q1 		$177K Buy
+1,269
New +$178K 0.01% 402
2025
Q4 		– Sell
-551
Closed -$61.2K – 685
2025
Q3 		$61.2K Buy
551
+244
+79% +$27.7K ﹤0.01% 561
2025
Q2 		$34K Sell
307
-183
-37% -$19.5K ﹤0.01% 650
2025
Q1 		$54.9K Buy
490
+380
+345% +$39.2K ﹤0.01% 559
2024
Q4 		$10.2K Sell
110
-497
-82% -$44.7K ﹤0.01% 835
2024
Q3 		$50.9K Hold
607
– – ﹤0.01% 574
2024
Q2 		$41.6K Hold
607
– – ﹤0.01% 598
2024
Q1 		$44.5K Sell
607
-398
-40% -$30.6K ﹤0.01% 576
2023
Q4 		$81.4K Sell
1,005
-65
-6% -$5.06K ﹤0.01% 472
2023
Q3 		$80.2K Hold
1,070
– – ﹤0.01% 453
2023
Q2 		$82.5K Buy
1,070
+198
+23% +$15.8K ﹤0.01% 449
2023
Q1 		$72.3K Buy
872
+350
+67% +$29K ﹤0.01% 473
2022
Q4 		$44.8K Sell
522
-30
-5% -$2.38K ﹤0.01% 537
2022
Q3 		$34K Buy
552
+30
+6% +$1.89K ﹤0.01% 540
2022
Q2 		$32K Hold
522
– – ﹤0.01% 585
2022
Q1 		$31K Buy
522
+22
+4% +$1.41K ﹤0.01% 587
2021
Q4 		$36K Hold
500
– – ﹤0.01% 613
2021
Q3 		$35K Hold
500
– – ﹤0.01% 555
2021
Q2 		$34K Hold
500
– – ﹤0.01% 539
2021
Q1 		$32K Sell
500
-71
-12% -$4.58K ﹤0.01% 518
2020
Q4 		$33K Buy
571
+71
+14% +$4.28K ﹤0.01% 509
2020
Q3 		$32K Hold
500
– – ﹤0.01% 435
2020
Q2 		$38K Sell
500
-685
-58% -$52.5K ﹤0.01% 398
2020
Q1 		$89K Buy
1,185
+565
+91% +$39K 0.01% 282
2019
Q4 		$40K Sell
620
-450
-42% -$29.3K ﹤0.01% 404
2019
Q3 		$68K Hold
1,070
– – 0.01% 331
2019
Q2 		$72K Sell
1,070
-1,615
-60% -$106K 0.01% 330
2019
Q1 		$207K Buy
+2,685
New +$178K 0.02% 189
2018
Q4 		– Sell
-2,685
Closed -$207K – 260
2018
Q3 		$207K Sell
2,685
-147
-5% -$11.1K 0.02% 189
2018
Q2 		$201K Sell
2,832
-65,100
-96% -$4.6M 0.02% 192
2018
Q1 		$4.99M Sell
67,932
-3,735
-5% -$297K 0.56% 48
2017
Q4 		$5.13M Sell
71,667
-21,230
-23% -$1.61M 0.56% 48
2017
Q3 		$7.69M Buy
92,897
+628
+0.7% +$48K 0.9% 31
2017
Q2 		$6.53M Sell
92,269
-2,763
-3% -$184K 0.76% 37
2017
Q1 		$6.46M Sell
95,032
-7,240
-7% -$509K 0.69% 38
2016
Q4 		$7.32M Sell
102,272
-32,268
-24% -$2.4M 0.84% 34
2016
Q3 		$106K Sell
134,540
-10,045
-7% -$816K 1.39% 24
2016
Q2 		$12.1M Buy
144,585
+215
+0.1% +$19.1K 1.45% 16
2016
Q1 		$13.3M Buy
144,370
+27,635
+24% +$2.49M 1.64% 12
2015
Q4 		$11.8M Buy
116,735
+2,100
+2% +$219K 1.49% 14
2015
Q3 		$11.2M Buy
114,635
+4,600
+4% +$511K 1.46% 15
2015
Q2 		$12.9M Buy
110,035
+2,710
+3% +$296K 1.57% 14
2015
Q1 		$10.5M Buy
107,325
+23,925
+29% +$2.43M 1.26% 18
2014
Q4 		$7.86M Buy
83,400
+14,500
+21% +$1.5M 0.94% 34
2014
Q3 		$7.33M Buy
68,900
+1,410
+2% +$138K 0.88% 37
2014
Q2 		$5.6M Buy
67,490
+57,640
+585% +$4.49M 0.68% 47
2014
Q1 		$698K Hold
9,850
– – 0.09% 169
2013
Q4 		$740K Hold
9,850
– – 0.1% 160
2013
Q3 		$619K Hold
9,850
– – 0.09% 171
2013
Q2 		$505K Buy
+9,850
New +$513K 0.07% 178

Other funds holding GILD

Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Salem Investment Counselors's GILD Position: Q2 2026 in Review

Salem Investment Counselors increased its Gilead Sciences (GILD) stake by 9.5% in Q2 2026, buying an estimated $15.8K and bringing the position to 1,389 shares worth $175K. The position accounts for ﹤0.01% of the portfolio, ranked #420.

Salem Investment Counselors first reported a position in GILD in Q2 2013 and has held it in 51 quarters since. The position peaked at $13.3M in Q1 2016. 1,333 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Salem Investment Counselors held 1,389 shares of Gilead Sciences worth $175K as of Q2 2026.
  • Salem Investment Counselors bought 120 Gilead Sciences shares in Q2 2026, an estimated $15.8K.
  • Gilead Sciences made up ﹤0.01% of Salem Investment Counselors's portfolio in Q2 2026, its #420 holding.
  • Salem Investment Counselors first reported a position in Gilead Sciences in Q2 2013 and has held it in 51 quarters since.
  • Salem Investment Counselors's Gilead Sciences position peaked at $13.3M in Q1 2016.
  • 1,333 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Salem Investment Counselors's 13F filing for Q2 2026, filed 14 Jul 2026.